HR Execs on the Move

Capital Health Plan

www.chp.org

 
Capital Health Plan is a Tallahassee, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.chp.org

  • Tallahassee, FL USA 32317
  • Phone: 877.247.6512

Executives

Name Title Contact Details

Similar Companies

Hamot Health Foundation

Hamot Health Foundation Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Hamot Health Foundation Inc. is based in Erie, PA. You can find more information on Hamot Health Foundation Inc. at www.hamot.org

The Green Organic Dutchman

The Green Organic Dutchman Ltd. produces farm grown, high quality organic medical cannabis in small batches using craft growing, all natural and organic principles. The Green Organic Dutchman Ltd. is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical marijuana. The Green Organic Dutchman carries out its principal activities producing marijuana from its facilities located on a 100-acre farm in Ancaster, Ontario, pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.

National Association of Community Health Centers

National Association of Community Health Centers, Inc. is a Washington, DC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Soul Community Planet

Soul Community Planet was born out of a vision to provide Holistic Hospitality experiences for individuals desiring to make positive choices for themselves and the planet. SCP Colorado Springs was the first concept unveiled in 2018 with SCP Redmond following in 2019 and SCP Depoe Bay in 2020.

Fibrocell Science

Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.